| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/29/2010 | EP2231199A1 Fluorescent marker for cell death in the eye |
| 09/29/2010 | EP2231198A2 Imaging dyes and use thereof |
| 09/29/2010 | EP2231188A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | CN1966088B Magnetic resonance imaging contrast using arabinogalactan as carrier |
| 09/29/2010 | CN101848734A Labelled IIGF binding peptides for imaging |
| 09/29/2010 | CN101845112A Preparation method of high-flexibility nuclear magnetic resonance imaging contrast agents based on high molecular nanometer particles |
| 09/29/2010 | CN101843907A Preparation method of SPIO.SiO2-WGA (Wheat Germ Agglutinin) intestinal wall targeting contrast agent |
| 09/29/2010 | CN101843906A Rhesus monkey seizure model and drug screening method thereof |
| 09/28/2010 | US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease |
| 09/28/2010 | US7803758 I kappa B kinase complex as a target for the treatment of Huntington's disease |
| 09/28/2010 | US7803752 Method of inducing neuronal production in the caudate nucleus and putamen |
| 09/28/2010 | US7803386 An immunogenic conjugate comprising a synthetic homopolymer of poly- gamma -glutamic acidpolypeptide covalently linked to a carrier, where the conjugate elicits an immune response against poly- gamma -glutamic acid ( gamma PGA) polypeptide; vaccine with fewer dosages; anthrax; diptheria |
| 09/28/2010 | US7803374 Targeted atherosclerosis treatment |
| 09/28/2010 | US7803352 Binding a contrasting complex comprising a contrast material and a thrombolytic or clot dissolving agent to the blood clot; exits body without causing either kidney toxicity, allergic reaction, or stimulation of atherogenesis |
| 09/28/2010 | CA2430366C Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 09/28/2010 | CA2366789C Fatty acid analogs for diagnosis of coronary artery disease |
| 09/23/2010 | WO2010108125A2 Psma-targeting compounds and uses thereof |
| 09/23/2010 | WO2010107178A2 Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes |
| 09/23/2010 | WO2010106169A1 Optical imaging agents |
| 09/23/2010 | WO2010076334A3 Intraoperative diagnosis of primary tumors and secondary tumors or metastases |
| 09/23/2010 | US20100242140 Modulation Of Plant Cell Wall Deposition |
| 09/23/2010 | US20100242124 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same |
| 09/23/2010 | US20100240977 Method for measuring the response of a tissue to an electromagnetic field |
| 09/23/2010 | US20100240020 Method of making biological components for devices by forced environmental adaptation |
| 09/23/2010 | US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors |
| 09/23/2010 | US20100239506 Methods for detection and determination of vitamin c by luminescence |
| 09/23/2010 | US20100239505 Apparatus with an echogenic coating and echogenic layer |
| 09/23/2010 | US20100239504 Imaging nucleic acid binding proteins |
| 09/23/2010 | US20100239503 Calcium-binding agents induce hair growth and/or nail growth |
| 09/23/2010 | US20100239502 In vivo expression analysis using ultrasound-induced transfection of reporter constructs |
| 09/23/2010 | US20100239501 Gene sensitive to bone/joint disease and use thereof |
| 09/23/2010 | US20100239500 Substituted triazine compounds for nerve regeneration |
| 09/23/2010 | US20100239498 Method of maintaining the function of liver tissue cells over long time |
| 09/23/2010 | DE102009013456A1 New nanoparticle, comprising core and immobilized ligand (for G-protein coupled receptor) in its surface, useful e.g. in drug targeting and tumor therapy, where the nanoparticle e.g. binds to cells having appropriate receptor to the ligand |
| 09/23/2010 | DE102009011607A1 Mikrokapsel zum Injizieren in den Blutkreislauf und Verfahren zur Aufnahme von eine Lokalisierung von Blut eines Patienten ermöglichenden Magnetresonanzbilddaten unter Verwendung von Mikrokapseln Microcapsule for injection into the bloodstream and method for recording of a location of a patient enabling magnetic resonance image data using blood of microcapsules |
| 09/23/2010 | CA2755965A1 Psma-targeting compounds and uses thereof |
| 09/23/2010 | CA2755770A1 Optical imaging agents |
| 09/22/2010 | EP2230244A1 Phosphorus polymers and their uses |
| 09/22/2010 | EP2229592A2 Recombinant bacteriophage for detection of nosocomial infection |
| 09/22/2010 | EP2229411A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
| 09/22/2010 | EP2229182A2 Polymeric drug carrier for image-guided delivery |
| 09/22/2010 | CN101842120A Contrast agents |
| 09/22/2010 | CN101842045A Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis |
| 09/22/2010 | CN101838289A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 09/22/2010 | CN101837255A Method and device for preparing micro-bubbles |
| 09/21/2010 | US7799947 radiolabelled amidine derivatives such as N-(3,5-dichlorobenzyl)-4-iodophenyl amidine suitable for imaging with tomography; selective antagonists of N-methylaspartic acid receptors, used for the diagnosis of pain, epilepsy, stroke, ischemia, spasms, neurodegenerative and psychological disorders |
| 09/21/2010 | US7799937 zinc complexed with triiodothyronine; improved potency, stability, absorbability, targeted delivery |
| 09/21/2010 | CA2445068C Azo compounds for type i phototherapy |
| 09/19/2010 | CA2692570A1 Diagnosis and treatment method of malignant tumours, and marker compounds |
| 09/16/2010 | WO2010104819A2 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery |
| 09/16/2010 | WO2010104253A1 Multifunctional contrast agent using biocompatible polymer and preparation method |
| 09/16/2010 | WO2010057944A9 Dye conjugate imaging agents |
| 09/16/2010 | WO2010048268A3 Manganese-oxo clusters as contrast agents for magnetic resonance imaging |
| 09/16/2010 | US20100234762 Compositions and methods for detecting oral neoplasm |
| 09/16/2010 | US20100234726 Device and method for safe location and marking of a biopsy cavity |
| 09/16/2010 | US20100233749 Device with biological component and method of making to achieve a desired figure of merit |
| 09/16/2010 | US20100233748 Device with biological component and method of making to achieve a desired transfer function |
| 09/16/2010 | US20100233219 Inorganic nanoparticle compromising an active substance immobilized on the surface and a polymer |
| 09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
| 09/16/2010 | US20100233097 Contrast agents |
| 09/16/2010 | US20100233096 Method to produce hyperpolarised carboxylates and sulphonates |
| 09/16/2010 | US20100233095 Conformationally dynamic peptides |
| 09/16/2010 | US20100233093 Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes |
| 09/16/2010 | US20100233092 In-vivo monitoring of circulating apoptotic cells |
| 09/16/2010 | US20100233091 Pyrazine Derivatives with Extended Conjugation and Methods of Using the same in Optical Applications |
| 09/16/2010 | US20100233090 Targeting vector-phospholipid conjugates |
| 09/16/2010 | US20100233089 Imaging of genetic material with magnetic resonance |
| 09/16/2010 | US20100233088 Method of identifying strategies for treatment or prevention of ventricular fibrilation and ventricular tachycardia |
| 09/16/2010 | US20100233087 Cyp1b1 nucleic acids and methods of use |
| 09/16/2010 | US20100233086 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 09/16/2010 | US20100233085 Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same |
| 09/16/2010 | US20100233084 Method for Delivery Across the Blood Brain Barrier |
| 09/16/2010 | US20100233083 Microparticles comprising a crosslinked polymer |
| 09/16/2010 | US20100233080 Antigen Binding Molecules that Bind EGFR, Vectors Encoding Same, and Uses Thereof |
| 09/16/2010 | DE102009012698A1 Partikel mit einer lumineszierenden anorganischen Schale, Verfahren zur Beschichtung von Partikeln sowie deren Verwendung Particles with a luminescent inorganic shell, methods for coating particles and the use thereof |
| 09/15/2010 | EP2228075A1 Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same |
| 09/15/2010 | EP2228074A1 A tumor targeting protein conjugate and a method for preparing the same |
| 09/15/2010 | EP2227236A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 09/15/2010 | CN101835556A Gold nanoparticle composition, DNA chip, near infrared absorbent, drug carrier for drug delivery system (DDS), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 09/15/2010 | CN101835498A Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 09/15/2010 | CN101830984A Double-targeted hybrid polypeptide for tumor diagnosis and treatment |
| 09/15/2010 | CN101830901A Selenite ion type compound and preparation method and application thereof |
| 09/15/2010 | CN101829339A Nano magnetic resonance imaging contrast agent and preparation method thereof |
| 09/15/2010 | CN101829120A Composition for treatment of external secretion disorders |
| 09/15/2010 | CN101496905B Marker for function check of stomach and intestine and preparation method thereof |
| 09/15/2010 | CN101474414B Preparation and application of polymer-coated magnetic nanoparticle contrast agent |
| 09/14/2010 | US7797034 3-D in-vivo imaging and topography using structured light |
| 09/14/2010 | US7795202 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response; repair of nervous system injuries or neurodegenerative disorders; tissue repair |
| 09/14/2010 | US7794967 Using small RNA molecules comprising metal binding region/domain as tool in detection of modulators which treat and prevent cell proliferation disorders |
| 09/14/2010 | US7794960 Predictive biomarkers in cancer therapy |
| 09/14/2010 | US7794747 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes |
| 09/14/2010 | US7794693 Targeting vector-phospholipid conjugates |
| 09/14/2010 | US7794692 Methods and compositions for detecting amyotrophic lateral sclerosis |
| 09/14/2010 | CA2483580C Biodegradable polymer for marking tissue and sealing tracts |
| 09/14/2010 | CA2370393C Dna sequence, and recombinant production of a gramineae allergen |
| 09/10/2010 | WO2010101298A1 Fluorescent mri probe |
| 09/10/2010 | WO2010100108A1 A method for the manufacture of a cross-linked micellar nanoparticle complex and products thereof |
| 09/10/2010 | WO2010099804A1 Magnetic resonance imaging of the liver |
| 09/10/2010 | WO2010067076A3 Pulse sequencing with hyperpolarisable nuclei |